Kokunai Akiko, Azusawa Hiroaki, Murota Hiroyuki, Ohhata Chika, Katayama Ichiro, Murata Shinsuke, Tadokoro Seiji
Department of Dermatology, Graduate School of Medicine, Osaka University.
Arerugi. 2006 Jun;55(6):662-6.
A 38-year-man developed diffuse erythema 3 days after the administration of 2-chlorodeoxyadenosine (cladribine or 2-CdA) and many other drugs for hairy cell leukemia (HCL). Patch-testing and scratch patch-testing showed positive reactions for clindamycin (10%, 30%) at 24 hours and 48 hours. Furthermore, provocation-testing showed positive reactions for sulfamethoxazole.trimethoprim, allopurinol, fluconazole, so our diagnosis was erythroderma-type drug eruption due to clindamycin, sulfamethoxazole-trimethoprim, allopurinol, fluconazole. Cutaneous side-effects associated with cladribine have seldom been described in cases of HCL. Our case suggests that there is a relationship between the drug hypersensitivity and the prolonged suppressed CD4 cell levels caused by cladribine.
一名38岁男性在使用2-氯脱氧腺苷(克拉屈滨或2-CdA)及许多其他药物治疗毛细胞白血病(HCL)3天后出现弥漫性红斑。斑贴试验和划痕斑贴试验显示,克林霉素(10%、30%)在24小时和48小时出现阳性反应。此外,激发试验显示磺胺甲恶唑-甲氧苄啶、别嘌醇、氟康唑呈阳性反应,因此我们的诊断是由克林霉素、磺胺甲恶唑-甲氧苄啶、别嘌醇、氟康唑引起的红皮病型药疹。HCL病例中很少描述与克拉屈滨相关的皮肤副作用。我们的病例表明,药物超敏反应与克拉屈滨导致的CD4细胞水平长期抑制之间存在关联。